1. Home
  2. MGRC vs FOLD Comparison

MGRC vs FOLD Comparison

Compare MGRC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGRC
  • FOLD
  • Stock Information
  • Founded
  • MGRC 1979
  • FOLD 2002
  • Country
  • MGRC United States
  • FOLD United States
  • Employees
  • MGRC N/A
  • FOLD N/A
  • Industry
  • MGRC Diversified Commercial Services
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGRC Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • MGRC Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • MGRC 2.8B
  • FOLD 2.5B
  • IPO Year
  • MGRC N/A
  • FOLD 2007
  • Fundamental
  • Price
  • MGRC $96.07
  • FOLD $9.60
  • Analyst Decision
  • MGRC Buy
  • FOLD Buy
  • Analyst Count
  • MGRC 2
  • FOLD 7
  • Target Price
  • MGRC $147.50
  • FOLD $30.29
  • AVG Volume (30 Days)
  • MGRC 129.0K
  • FOLD 4.9M
  • Earning Date
  • MGRC 10-23-2025
  • FOLD 11-04-2025
  • Dividend Yield
  • MGRC 2.03%
  • FOLD N/A
  • EPS Growth
  • MGRC N/A
  • FOLD N/A
  • EPS
  • MGRC 5.90
  • FOLD N/A
  • Revenue
  • MGRC $931,222,000.00
  • FOLD $598,704,000.00
  • Revenue This Year
  • MGRC $5.46
  • FOLD $21.12
  • Revenue Next Year
  • MGRC $4.31
  • FOLD $21.23
  • P/E Ratio
  • MGRC $16.20
  • FOLD N/A
  • Revenue Growth
  • MGRC 4.78
  • FOLD 21.28
  • 52 Week Low
  • MGRC $94.99
  • FOLD $5.51
  • 52 Week High
  • MGRC $129.93
  • FOLD $10.36
  • Technical
  • Relative Strength Index (RSI)
  • MGRC 19.44
  • FOLD 68.56
  • Support Level
  • MGRC $106.16
  • FOLD $8.69
  • Resistance Level
  • MGRC $106.56
  • FOLD $9.65
  • Average True Range (ATR)
  • MGRC 2.56
  • FOLD 0.36
  • MACD
  • MGRC -0.97
  • FOLD 0.03
  • Stochastic Oscillator
  • MGRC 4.28
  • FOLD 96.10

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: